Your browser doesn't support javascript.
loading
KEYNOTE-033: Randomized phase 3 study of pembrolizumab vs docetaxel in previously treated, PD-L1-positive, advanced NSCLC.
Ren, Shengxiang; Feng, Jifeng; Ma, Shenglin; Chen, HuaJun; Ma, Zhiyong; Huang, Cheng; Zhang, Li; He, Jianxing; Wang, Changli; Zhou, Jianying; Danchaivijtr, Pongwut; Wang, Chin-Chou; Vynnychenko, Ihor; Wang, Kai; Orlandi, Francisco; Sriuranpong, Virote; Li, Ben; Ge, Jun; Dang, Thao; Zhou, Caicun.
Affiliation
  • Ren S; Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
  • Feng J; Oncology Department, Jiangsu Cancer Hospital, Nanjing, China.
  • Ma S; Department of Thoracic Oncology, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Zhejiang University Cancer Center, Zhejiang, People's Republic of China.
  • Chen H; Guangdong Provincial People's Hospital, Guangdong Lung Cancer Institute, Guangzhou, China.
  • Ma Z; Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, Zhengzhou, China.
  • Huang C; Department of Pneumology, Fujian Provincial Cancer Hospital, Fuzhou, China.
  • Zhang L; Cancer Center, Sun Yat-Sen University, Guangzhou, China.
  • He J; Department of Thoracic Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • Wang C; Department of Biotherapy 17F, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China.
  • Zhou J; Department of Respiratory Medicine, The First Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, China.
  • Danchaivijtr P; Division of Medical Oncology, Siriraj Hospital, Bangkok, Thailand.
  • Wang CC; Chang Gung Medical Foundation, Kaohsiung, Taiwan.
  • Vynnychenko I; RMI Sumy Regional Clinical Oncology Dispensary, Sumy State University, Sumy, Ukraine.
  • Wang K; Department of Respiration Medicine, The Second Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, China.
  • Orlandi F; Region Metropolitana de Santiago, Orlandi Oncologia, Providencia, Chile.
  • Sriuranpong V; Medical Oncology Unit, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
  • Li B; MSD China, Beijing, China.
  • Ge J; MSD China, Shanghai, China.
  • Dang T; Merck & Co., Inc., Rahway, NJ, USA.
  • Zhou C; Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
Int J Cancer ; 153(3): 623-634, 2023 Aug 01.
Article in En | MEDLINE | ID: mdl-37141294
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Clinical_trials Limits: Humans Language: En Journal: Int J Cancer Year: 2023 Document type: Article Affiliation country: China Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Clinical_trials Limits: Humans Language: En Journal: Int J Cancer Year: 2023 Document type: Article Affiliation country: China Country of publication: United States